Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Michel

Showing results (51-60 of 62) with videos related to

Pageof 7
Sort By:
Cancer Research|June 17, 2010
ADAM17 regulates epidermal growth factor receptor expression through the activation of Notch1 in non-small cell lung cancerAnja Baumgart, Stefan Seidl, Petros Vlachou, et al.
Nature Communications|May 26, 2019
Contemporaneous 3D characterization of acute and chronic myocardial I/R injury and responseSimon F Merz, Sebastian Korste, Lea Bornemann, et al.
Nature Communications|June 21, 2019
Publisher Correction: Contemporaneous 3D characterization of acute and chronic myocardial I/R injury and responseSimon F Merz, Sebastian Korste, Lea Bornemann, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|April 6, 2026
Transthyretin stabilizer therapy increases naturally-occurring antibodies in ATTR cardiomyopathyStephan Settelmeier, Daniel Agranovski, Maximilian Steinhardt, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|August 4, 2020
Assessment of coronary artery disease during hospitalization for cancer treatmentSimone M Mrotzek, Alessia Lena, Sara Hadzibegovic, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 7, 2026
Prognostic parameters and detection of cardiac amyloidosis with hybrid <sup>18</sup>F-Florbetaben-PET/MRI: an exploratory observational studyLukas Kessler, Wibke Tonscheidt, Kai Nassenstein, et al.
EJNMMI Research|June 12, 2026
Early timepoint <sup>99m</sup>Tc-DPD whole body scintigraphy and quantitative SPECT/CT imaging for diagnosis of cardiac ATTR amyloidosisStephan Settelmeier, Lukas Kessler, Noah Hammersen, et al.
European Heart Journal|August 14, 2021
Targeting early stages of cardiotoxicity from anti-PD1 immune checkpoint inhibitor therapyLars Michel, Iris Helfrich, Ulrike Barbara Hendgen-Cotta, et al.
ESC Heart Failure|November 6, 2024
Real-world characteristics and treatment of cardiac transthyretin amyloidosis: A multicentre, observational studyRichard J Nies, Svenja Ney, Ingrid Kindermann, et al.
European Heart Journal|August 30, 2025
Heart Failure Therapy in Patients with Advanced Cancer Receiving Specialized Palliative Care (EMPATICC trial)Markus S Anker, Amir A Mahabadi, Matthias Totzeck, et al.
Pageof 7

Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
Cancer Research|June 17, 2010
ADAM17 regulates epidermal growth factor receptor expression through the activation of Notch1 in non-small cell lung cancerAnja Baumgart, Stefan Seidl, Petros Vlachou, et al.
Nature Communications|May 26, 2019
Contemporaneous 3D characterization of acute and chronic myocardial I/R injury and responseSimon F Merz, Sebastian Korste, Lea Bornemann, et al.
Nature Communications|June 21, 2019
Publisher Correction: Contemporaneous 3D characterization of acute and chronic myocardial I/R injury and responseSimon F Merz, Sebastian Korste, Lea Bornemann, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|April 6, 2026
Transthyretin stabilizer therapy increases naturally-occurring antibodies in ATTR cardiomyopathyStephan Settelmeier, Daniel Agranovski, Maximilian Steinhardt, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|August 4, 2020
Assessment of coronary artery disease during hospitalization for cancer treatmentSimone M Mrotzek, Alessia Lena, Sara Hadzibegovic, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 7, 2026
Prognostic parameters and detection of cardiac amyloidosis with hybrid <sup>18</sup>F-Florbetaben-PET/MRI: an exploratory observational studyLukas Kessler, Wibke Tonscheidt, Kai Nassenstein, et al.
EJNMMI Research|June 12, 2026
Early timepoint <sup>99m</sup>Tc-DPD whole body scintigraphy and quantitative SPECT/CT imaging for diagnosis of cardiac ATTR amyloidosisStephan Settelmeier, Lukas Kessler, Noah Hammersen, et al.
European Heart Journal|August 14, 2021
Targeting early stages of cardiotoxicity from anti-PD1 immune checkpoint inhibitor therapyLars Michel, Iris Helfrich, Ulrike Barbara Hendgen-Cotta, et al.
ESC Heart Failure|November 6, 2024
Real-world characteristics and treatment of cardiac transthyretin amyloidosis: A multicentre, observational studyRichard J Nies, Svenja Ney, Ingrid Kindermann, et al.
European Heart Journal|August 30, 2025
Heart Failure Therapy in Patients with Advanced Cancer Receiving Specialized Palliative Care (EMPATICC trial)Markus S Anker, Amir A Mahabadi, Matthias Totzeck, et al.
Pageof 7